Porntip Chavalitshewinkoon-Petmitr
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Porntip Chavalitshewinkoon-Petmitr has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
Prapon Wilairat
Department of Biochemistry Faculty of Science Mahidol University Bangkok Thailand
3 shared publicationsSongsak Petmitr
3 shared publications- Mathirut Mungthin
Department of Parasitology, Phramongkutklao College of Medicine, Bangkok, Thailand
2 shared publications Saovanee Leelayoova
2 shared publications- Zulhainan Hamzah
Department of Protozoology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
2 shared publications - Chayaphat Wongsombat
Protein-Ligand Engineering and Molecular Biology Laboratory, Medical Molecular Biology Research Unit, National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), Khlong Luang, Thailand
1 shared publication
Latest Publications
- 1 November 2011
- Published by Elsevier in Molecular and Biochemical Parasitology
- Vol. 180 (1) , 1-7
Molecular characterization of Plasmodium falciparum putative polynucleotide kinase/phosphatase
- 1 November 2011
- Published by Elsevier in Molecular and Biochemical Parasitology
- Vol. 180 (1) , 1-7
Molecular characterization of Plasmodium falciparum putative polynucleotide kinase/phosphatase
- Open Access
- 18 August 2011
- Published by Springer Nature in Malaria Journal
- Vol. 10 (1) , 242
Global gene expression profiling of Plasmodium falciparum in response to the anti-malarial drug pyronaridine
Pyronaridine (PN) and chloroquine (CQ) are structurally related anti-malarial drugs with primarily the same mode of action. However, PN is effective against several multidrug-resistant lines of Plasmodium falciparum, including CQ resistant lines, suggestive of important operational differences between the two drugs.
- 18 August 2011
- Published by Springer Nature in Malaria Journal
- Vol. 10 (1) , 242
Open AccessGlobal gene expression profiling of Plasmodium falciparum in response to the anti-malarial drug pyronaridine
Pyronaridine (PN) and chloroquine (CQ) are structurally related anti-malarial drugs with primarily the same mode of action. However, PN is effective against several multidrug-resistant lines of Plasmodium falciparum, including CQ resistant lines, suggestive of important operational differences between the two drugs.
- 5 October 2010
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 83 (4) , 909-913
Development of Multiplex Real-Time Polymerase Chain Reaction for Detection of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii in Clinical Specimens
Multiplex real-time polymerase chain reaction (PCR) was developed for differential detection of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii. Specific primers were designed for all three species, and then differentiation of E. histolytica and E. dispar was achieved simultaneously using a hybridization probe and melting curve analysis, whereas E. moshkovskii was detected with a separate probe under the same condition. This assay detected as little as 0.2 pg of E. histolytica DNA and 2 pg each for E. dispar and E. moshkovskii DNA. Thirty-five clinical samples suspected to be E. histolytica infection by microscopy were tested. The results showed 32 positive samples; four samples were E. histolytica and 28 samples were E. dispar. Interestingly, one E. dispar positive sample showed a mixed infection with E. moshkovskii. This is the first report of E. moshkovskii infection from Thailand and this assay is currently the most rapid and sensitive method to differentiate these human amoebas.
- 5 October 2010
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 83 (4) , 909-913
Development of Multiplex Real-Time Polymerase Chain Reaction for Detection of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii in Clinical Specimens
Multiplex real-time polymerase chain reaction (PCR) was developed for differential detection of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii. Specific primers were designed for all three species, and then differentiation of E. histolytica and E. dispar was achieved simultaneously using a hybridization probe and melting curve analysis, whereas E. moshkovskii was detected with a separate probe under the same condition. This assay detected as little as 0.2 pg of E. histolytica DNA and 2 pg each for E. dispar and E. moshkovskii DNA. Thirty-five clinical samples suspected to be E. histolytica infection by microscopy were tested. The results showed 32 positive samples; four samples were E. histolytica and 28 samples were E. dispar. Interestingly, one E. dispar positive sample showed a mixed infection with E. moshkovskii. This is the first report of E. moshkovskii infection from Thailand and this assay is currently the most rapid and sensitive method to differentiate these human amoebas.
- 1 September 2009
- Vol. 40 (5) , 877-885
PARTIAL PURIFICATION AND CHARACTERIZATION OF TRICHOMONAS VAGINALIS DNA TOPOISOMERASE II
DNA topoisomerases regulate conformational changes in DNA topology by catalyzing the breakage and rejoining of DNA strands during the cell cycle. These processes are essential for the multiplication of cells, and inhibition of these reactions stops cell division and cell growth. Drug resistance to Trichomonas vaginalis, a common sexually transmitted protozoan parasite, is increasing worldwide, and DNA topoisomerase II may provide a new target for anti-trichomonal drug development. In this study, T. vaginalis DNA topoisomerase II was partially purified from a large scale axenic culture using fast protein liquid chromatography with a yield of 0.1.6% and 17-fold purification. The partially purified enzyme was strictly dependent oil ATP and Mg2+ with optimal concentration of 1 and 10 mM respectively for relaxation activity. T vaginalis DNA topoisomerase II activity was inhibited by m-amsacrine (m-AMSA) and ofloxacin at minimum inhibitory concentration (MIC) of 250 mu M. At this concentration, ciprofloxacin showed incomplete inhibition whereas metronidazole was inactive. DW6, a DNA quadruplex binder, was the most active compound with MIC of 62.5 mu M, suggesting the potential for development of such compounds as selective anti-trichomonal drugs in the future.
- 1 September 2009
- Vol. 40 (5) , 877-885
PARTIAL PURIFICATION AND CHARACTERIZATION OF TRICHOMONAS VAGINALIS DNA TOPOISOMERASE II
DNA topoisomerases regulate conformational changes in DNA topology by catalyzing the breakage and rejoining of DNA strands during the cell cycle. These processes are essential for the multiplication of cells, and inhibition of these reactions stops cell division and cell growth. Drug resistance to Trichomonas vaginalis, a common sexually transmitted protozoan parasite, is increasing worldwide, and DNA topoisomerase II may provide a new target for anti-trichomonal drug development. In this study, T. vaginalis DNA topoisomerase II was partially purified from a large scale axenic culture using fast protein liquid chromatography with a yield of 0.1.6% and 17-fold purification. The partially purified enzyme was strictly dependent oil ATP and Mg2+ with optimal concentration of 1 and 10 mM respectively for relaxation activity. T vaginalis DNA topoisomerase II activity was inhibited by m-amsacrine (m-AMSA) and ofloxacin at minimum inhibitory concentration (MIC) of 250 mu M. At this concentration, ciprofloxacin showed incomplete inhibition whereas metronidazole was inactive. DW6, a DNA quadruplex binder, was the most active compound with MIC of 62.5 mu M, suggesting the potential for development of such compounds as selective anti-trichomonal drugs in the future.
- Open Access
- 26 June 2008
- Published by Springer Nature in Malaria Journal
- Vol. 7 (1) , 113
Suppression of Plasmodium falciparum by serum collected from a case of Plasmodium vivax infection
It has frequently been reported that Plasmodium vivax suppressed Plasmodium falciparum and ameliorated disease severity in patients infected with these two species simultaneously. The authors investigate the hypothesis that immunological responses stimulated by P. vivax may play a role in suppressing co-infecting P. falciparum.
- 26 June 2008
- Published by Springer Nature in Malaria Journal
- Vol. 7 (1) , 113
Open AccessSuppression of Plasmodium falciparum by serum collected from a case of Plasmodium vivax infection
It has frequently been reported that Plasmodium vivax suppressed Plasmodium falciparum and ameliorated disease severity in patients infected with these two species simultaneously. The authors investigate the hypothesis that immunological responses stimulated by P. vivax may play a role in suppressing co-infecting P. falciparum.
- 1 September 2006
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 44 (9) , 3196-3200
Differential Detection of Entamoeba histolytica , Entamoeba dispar , and Entamoeba moshkovskii by a Single-Round PCR Assay
A single-round PCR assay was developed for detection and differential diagnosis of the three Entamoeba species found in humans, Entamoeba moshkovskii , Entamoeba histolytica , and Entamoeba dispar , that are morphologically identical as both cysts and trophozoites. A conserved forward primer was derived from the middle of the small-subunit rRNA gene, and reverse primers were designed from signature sequences specific to each of these three Entamoeba species. PCR generates a 166-bp product with E. histolytica DNA, a 752-bp product with E. dispar DNA, and a 580-bp product with E. moshkovskii DNA. Thirty clinical specimens were examined, and the species present were successfully detected and differentiated using this assay. It was possible to detect as little as 10 pg of E. moshkovskii and E. histolytica DNA, while for E. dispar the sensitivity was about 20 pg of DNA. Testing with DNA from different pathogens, including bacteria and other protozoa, confirmed the high specificity of the assay. We propose the use of this PCR assay as an accurate, rapid, and effective diagnostic method for the detection and discrimination of these three morphologically indistinguishable Entamoeba species in both routine diagnosis of amoebiasis and epidemiological surveys.
- 1 September 2006
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 44 (9) , 3196-3200
Differential Detection of Entamoeba histolytica , Entamoeba dispar , and Entamoeba moshkovskii by a Single-Round PCR Assay
A single-round PCR assay was developed for detection and differential diagnosis of the three Entamoeba species found in humans, Entamoeba moshkovskii , Entamoeba histolytica , and Entamoeba dispar , that are morphologically identical as both cysts and trophozoites. A conserved forward primer was derived from the middle of the small-subunit rRNA gene, and reverse primers were designed from signature sequences specific to each of these three Entamoeba species. PCR generates a 166-bp product with E. histolytica DNA, a 752-bp product with E. dispar DNA, and a 580-bp product with E. moshkovskii DNA. Thirty clinical specimens were examined, and the species present were successfully detected and differentiated using this assay. It was possible to detect as little as 10 pg of E. moshkovskii and E. histolytica DNA, while for E. dispar the sensitivity was about 20 pg of DNA. Testing with DNA from different pathogens, including bacteria and other protozoa, confirmed the high specificity of the assay. We propose the use of this PCR assay as an accurate, rapid, and effective diagnostic method for the detection and discrimination of these three morphologically indistinguishable Entamoeba species in both routine diagnosis of amoebiasis and epidemiological surveys.
- Open Access
- 1 July 2003
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 52 (2) , 287-289
In vitro susceptibility of Trichomonas vaginalis to AT-specific minor groove binding drugs
Trichomoniasis is one of the most common sexually transmitted diseases, with around 120 million world-wide suffering from Trichomonas vaginalis-induced vaginitis every year. Although trichomoniasis can be treated with metronidazole, the prevalence of metronidazole-resistant T. vaginalis seems to be increasing. Since the percentage of AT base pairs in T. vaginalis DNA (71%) is very much higher than in human cells, in this study a series of bisquaternary quinolinium salt compounds with high AT-binding specificity were tested for their antitrichomonal activities. Minimum inhibitory concentrations (MICs) were determined for these compounds against a local strain of T. vaginalis in culture. Among 14 bisquaternary quinolinium compounds tested, an N-ethyl derivative was the most effective drug against T. vaginalis, being nearly as potent (MIC = 0.16 µM) as metronidazole (MIC = 0.096 µM), and with low toxicity towards human cells. The nature of the substitution at the quinolinium quaternary centre appears to be important in terms of effectiveness of bisquaternary compounds against the parasite. In contrast, no clear relationships could be seen for substituents on the quinolinium ring; Me and Cl substituted analogues showed higher activity against trichomonads, whereas OMe, NHMe and NH2 substituents decreased activity.
- 1 July 2003
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 52 (2) , 287-289
Open AccessIn vitro susceptibility of Trichomonas vaginalis to AT-specific minor groove binding drugs
Trichomoniasis is one of the most common sexually transmitted diseases, with around 120 million world-wide suffering from Trichomonas vaginalis-induced vaginitis every year. Although trichomoniasis can be treated with metronidazole, the prevalence of metronidazole-resistant T. vaginalis seems to be increasing. Since the percentage of AT base pairs in T. vaginalis DNA (71%) is very much higher than in human cells, in this study a series of bisquaternary quinolinium salt compounds with high AT-binding specificity were tested for their antitrichomonal activities. Minimum inhibitory concentrations (MICs) were determined for these compounds against a local strain of T. vaginalis in culture. Among 14 bisquaternary quinolinium compounds tested, an N-ethyl derivative was the most effective drug against T. vaginalis, being nearly as potent (MIC = 0.16 µM) as metronidazole (MIC = 0.096 µM), and with low toxicity towards human cells. The nature of the substitution at the quinolinium quaternary centre appears to be important in terms of effectiveness of bisquaternary compounds against the parasite. In contrast, no clear relationships could be seen for substituents on the quinolinium ring; Me and Cl substituted analogues showed higher activity against trichomonads, whereas OMe, NHMe and NH2 substituents decreased activity.
- 1 December 2001
- Vol. 32 (4) , 733-8
Partial purification of mitochondrial DNA topoisomerase II from Plasmodium falciparum and its sensitivity to inhibitors.
Mitochondria of Plasmodium falciparum (K1 strain) were isolated by differential centrifugation. Mitochondrial DNA topoisomerase II from P. falciparum was partially purified using fast protein liquid chromatography(FPLC). Parasite mitochondria contained approximately 8% of DNA topoisomerase II activity compared with its nuclear fraction. The effects of fluoroquinolones, inhibitors of bacterial DNA topoisomerase II or DNA gyrase, against partially purified P. falciparum mitochondrial DNA topoisomerase II were investigated using a decatenation assay. Minimum inhibitory concentrations (MIC) of ofloxacin, ciprofloxacin and norfloxacin were > 1, 10 and 100 mM, compared with that of >0.5 and 10 mM for eukaryotic DNA topoisomerase II inhibitor etoposide (VP-16) and amsacrine, respectively. The results indicate that partially purified mitochondrial DNA topoisomerase II was insensitive to fluoroquinolones and it is suggested that their inhibitory effects on P. falciparum growth may be directed against plastid DNA topoisomerase II.
- 1 December 2001
- Vol. 32 (4) , 733-8
Partial purification of mitochondrial DNA topoisomerase II from Plasmodium falciparum and its sensitivity to inhibitors.
Mitochondria of Plasmodium falciparum (K1 strain) were isolated by differential centrifugation. Mitochondrial DNA topoisomerase II from P. falciparum was partially purified using fast protein liquid chromatography(FPLC). Parasite mitochondria contained approximately 8% of DNA topoisomerase II activity compared with its nuclear fraction. The effects of fluoroquinolones, inhibitors of bacterial DNA topoisomerase II or DNA gyrase, against partially purified P. falciparum mitochondrial DNA topoisomerase II were investigated using a decatenation assay. Minimum inhibitory concentrations (MIC) of ofloxacin, ciprofloxacin and norfloxacin were > 1, 10 and 100 mM, compared with that of >0.5 and 10 mM for eukaryotic DNA topoisomerase II inhibitor etoposide (VP-16) and amsacrine, respectively. The results indicate that partially purified mitochondrial DNA topoisomerase II was insensitive to fluoroquinolones and it is suggested that their inhibitory effects on P. falciparum growth may be directed against plastid DNA topoisomerase II.
- Open Access
- 1 January 2001
- Published by Wiley in Tropical Medicine & International Health
- Vol. 6 (1) , 42-45
Inhibitory effects of 9-anilinoacridines on Plasmodium falciparum gametocytes
- 1 January 2001
- Published by Wiley in Tropical Medicine & International Health
- Vol. 6 (1) , 42-45
Open AccessInhibitory effects of 9-anilinoacridines on Plasmodium falciparum gametocytes
- 1 December 2000
- Published by Elsevier in Parasitology International
- Vol. 49 (4) , 279-288
Partial purification and characterization of mitochondrial DNA polymerase from Plasmodium falciparum
- 1 December 2000
- Published by Elsevier in Parasitology International
- Vol. 49 (4) , 279-288
Partial purification and characterization of mitochondrial DNA polymerase from Plasmodium falciparum